gimli
ANTHEM stock analysis context
ANTHEM BIOSCIENCES Stock Context for AI Screening
ANTHEM BIOSCIENCES LTD is a mid-cap stock in Healthcare. This page summarizes key screening signals for ANTHEM BIOSCIENCES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about ANTHEMPrice
₹777.10
1M return
+2.35%
3M return
+13.96%
Market cap
₹43,650.78 cr
PE
92.25
ROE
+21.83%
RSI
55.28
Turnover
₹25.41 cr
Why it can matter in screens
- Momentum: ANTHEM is above 50DMA, above 200DMA; RSI is 55.28.
- Returns: 1M +2.35%, 3M +13.96%, 6M +22.36%.
- Liquidity: latest turnover is ₹25.41 cr.
- Valuation: PE 92.25, PB n/a, ROE +21.83%, ROCE +30.11%.
- Growth: 3Y sales CAGR +14.42%, 3Y profit CAGR +3.62%.
Try these prompts
- Analyze ANTHEM BIOSCIENCES with valuation, momentum and industry peers
- Compare ANTHEM with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare ANTHEM with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.